Compare NNNN & COFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NNNN | COFS |
|---|---|---|
| Founded | 2021 | 1898 |
| Country | Germany | United States |
| Employees | 27 | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 417.8M | 493.9M |
| IPO Year | N/A | 1995 |
| Metric | NNNN | COFS |
|---|---|---|
| Price | $9.25 | $33.91 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $34.00 |
| AVG Volume (30 Days) | 33.6K | ★ 83.3K |
| Earning Date | 04-07-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 3.86% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.91 |
| Revenue | N/A | ★ $227,624,000.00 |
| Revenue This Year | N/A | $22.13 |
| Revenue Next Year | N/A | $4.47 |
| P/E Ratio | $446.57 | ★ $37.03 |
| Revenue Growth | N/A | ★ 63.64 |
| 52 Week Low | $8.30 | $26.10 |
| 52 Week High | $54.90 | $34.90 |
| Indicator | NNNN | COFS |
|---|---|---|
| Relative Strength Index (RSI) | 37.56 | 52.21 |
| Support Level | $8.30 | $30.09 |
| Resistance Level | $29.98 | $34.88 |
| Average True Range (ATR) | 1.31 | 1.32 |
| MACD | 0.58 | -0.05 |
| Stochastic Oscillator | 33.89 | 72.27 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
ChoiceOne Financial Services Inc is a full-service banking institution. It is engaged in the business of providing personal and business banking solutions, borrowing solutions, and treasury notes and bonds services. The bank's product and services portfolio consist of time, savings and demand deposits, safe deposit services, automated transaction machine services, commercial and consumer loans, commercial lending to business, industry, agricultural, construction, inventory, and real estate categories. Its primary market area is Kent, Muskegon, Newaygo, and Ottawa counties in western Michigan, and Lapeer, Macomb, and St. Clair counties in southeastern Michigan in the communities where the Bank's respective offices are located.